Doença Ocular Diabética
Open accessAbstract
A diabetes mellitus é uma doença metabólica crónica caracterizada por uma hiperglicémia mantida, o que leva a complicações macro e microvasculares. O olho é um dos principais órgãos atingidos nesta patologia e a retinopatia diabética a mais conhecida complicação microvascular e a principal causa de cegueira em indivíduos em idade activa. Todavia, a doença ocular diabética não se caracteriza apenas pela retinopatia diabética. Outras manifestações oculares importantes da diabetes mellitus são a catarata, o glaucoma, aneuropatia óptica isquémica, as parésias óculo-motoras e as erosões queráticas. Neste artigo de revisão destacamos a retinopatia diabética como a mais importante e característica complicação da diabetes mellitus, mas também as complicações menos conhecidas, com o objectivo de alertar e sensibilizar médicos não-oftalmologistas que lidam com indivíduos diabéticos, de modo a promover o diagnóstico e tratamento atempados destas alterações visualmente debilitantes.Palavras-chave: Complicações da Diabetes; Diabetes Mellitus; Retinopatia Diabética.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There are many diabetes-related ocular diseases, such as cataract, glaucoma, ischemic optic neuropathy, cranial nerve palsies, and recurrent corneal erosion syndrome.
“There are many diabetes-related ocular diseases, such as cataract, glaucoma, ischemic optic neuropathy, cranial nerve palsies, and recurrent corneal erosion syndrome (102).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · see citing works
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216 · see citing works
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,267 · see citing works
Wilkinson, C. P., Ferris, F. L., Klein, R., Lee, P. P., Agardh, C., Davis, M., Dills, D. G., Kampik, A., Pararajasegaram, R., & Verdaguer, J. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,786 · see citing works
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703 · see citing works
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030
Rathmann, W., & Giani, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2568 · Cited by 2,008 · see citing works
The Prevalence of Diabetic Retinopathy Among Adults in the United States
Kempen, J. H., O'Colmain, B. J., Leske, M. C., Sm, H., Klein, R., Moss, S. E., Taylor, H. R., & Hamman, R. F. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.552 · Cited by 1,151 · see citing works
Oxidative Stress and Diabetic Retinopathy
Kowluru, R. A., & Chan, P.-S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/43603 · Cited by 749 · see citing works
The 14-year incidence of visual loss in a diabetic population,
Moss, S. E. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)96025-0 · Cited by 671 · see citing works
Epidemiology of diabetic retinopathy and macular oedema: A systematic review
Williams, R., Airey, M., Baxter, H., Forrester, J., Kennedy-Martin, T., & Girach, A. (2004) · Eye · doi:10.1038/sj.eye.6701476 · Cited by 472 · see citing works
Vascular Endothelial Growth Factor A in Intraocular Vascular Disease
Miller, J. W., LeCouter, J. E., Strauss, E. C., & Ferrara, N. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.038 · Cited by 408 · see citing works
Endothelium‐specific platelet‐derived growth factor‐B ablation mimics diabetic retinopathy
Enge, M., Bjarnegård, M., Gerhardt, H., Gustafsson, E., Kalén, M., Asker, N., Hammes, H., Shani, M., Fässler, R., & Betsholtz, C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf418 · Cited by 402 · see citing works
The pathogenesis of diabetic retinopathy: old concepts and new questions
Cai, J., & Boulton, M. E. (2002) · Eye · doi:10.1038/sj.eye.6700133 · Cited by 345 · see citing works
Haller, J. A. (2010) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.21 · Cited by 296 · see citing works
Vascular endothelial growth factor and diabetic complications
Wirostko, B. M., Wong, T. Y., & Simó, R. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.09.002 · Cited by 241 · see citing works
The role of advanced glycation in the pathogenesis of diabetic retinopathy
Stitt, A. W. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00035-2 · Cited by 226 · see citing works
Anti-vascular endothelial growth factor therapy for diabetic macular edema
Boyer, D. S., Hopkins, J. J., Sorof, J. M., & Ehrlich, J. S. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813512360 · Cited by 195 · see citing works
Ocular Associations of Diabetes Other Than Diabetic Retinopathy
Jeganathan, V. S. E., Wang, J. J., & Wong, T. Y. (2008) · Diabetes Care · doi:10.2337/dc08-0342 · Cited by 184 · see citing works
Cardillo, J. A., Melo, L. A. S., Costa, R. A., Skaf, M., Belfort, R., Filho, A. A. D. S. L., Farah, M. E., & Kuppermann, B. D. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.03.023 · Cited by 147 · see citing works
Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
Robison, W. G., Nagata, M., Laver, N., Hohman, T. C., & Kinoshita, J. H. (1989) · PubMed · Cited by 144 · see citing works
Role of inflammation in the pathogenesis of diabetic retinopathy
El‐Asrar, A. M. A. (2012) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.92118 · Cited by 126 · see citing works
Early photocoagulation in patients with either type I or type II diabetes
Ferris, F. L. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70200-4 · Cited by 117 · see citing works
Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor
Tombran‐Tink, J., & Barnstable, C. J. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00074-1 · Cited by 109 · see citing works
The role of oxidative stress in diabetic retinopathy
Gürler, B., Vural, H., Yılmaz, N., Oğuz, H., Satici, A., & Aksoy, N. (2000) · Eye · doi:10.1038/eye.2000.193 · Cited by 88 · see citing works
Genetics in Diabetic Retinopathy: Current Concepts and New Insights
Simó‐Servat, O., Hernández, C., & Simó, R. (2013) · Current Genomics · doi:10.2174/13892029113149990008 · Cited by 84 · see citing works
Anti-VEGF Therapy for Diabetic Macular Edema
Stewart, M. W. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0510-4 · Cited by 84 · see citing works
Uckermann, O., Kutzera, F., Wolf, A., Pannicke, T., Reichenbach, A., Wiedemann, P., Wolf, S., & Bringmann, A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092353 · Cited by 82 · see citing works
Groeneveld, Y., Petri, H., Hermans, J., & Springer, M. P. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00003.x · Cited by 78 · see citing works
Klein, R. (1987) · International Ophthalmology Clinics · doi:10.1097/00004397-198702740-00003 · Cited by 73 · see citing works
Expression of aquaporin-1 immunoreactivity by photoreceptor cells in the mouse retina
Iandiev, I., Pannicke, T., Reichel, M. B., Wiedemann, P., Reichenbach, A., & Bringmann, A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.06.046 · Cited by 70 · see citing works
Ocular manifestations of diabetes mellitus
Stanga, P. E., Boyd, S. R., & HAMILTON, A. M. (1999) · Current Opinion in Ophthalmology · doi:10.1097/00055735-199912000-00018 · Cited by 68 · see citing works
The role of protein kinase C in the development of the complications of diabetes
Ways, D. K., & Sheetz, M. J. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)60019-5 · Cited by 65 · see citing works
Targeting Leukostasis for the Treatment of Early Diabetic Retinopathy
Patel, N. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152909789007052 · Cited by 52 · see citing works
Ling, R., Ramsewak, V., Taylor, D., & Jacob, J. (2002) · Eye · doi:10.1038/sj/eye/6700081 · Cited by 52 · see citing works
Yoshii, H., Uchino, H., Ohmura, C., Watanabe, K., Tanaka, Y., & Kawamori, R. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00221-7 · Cited by 39 · see citing works
Stewart, M. W. (2012) · Current Diabetes Reviews · doi:10.2174/157339912800840488 · Cited by 38 · see citing works
Chibber, R., Pa, M., & KOHNER, E. M. (1999) · PubMed · Cited by 38 · see citing works
Ocular Ischemic Syndrome in Diabetic Patients
Ino-ue, M. (1999) · Japanese Journal of Ophthalmology · doi:10.1016/s0021-5155(98)00057-4 · Cited by 35 · see citing works
A review of non-retinal ocular complications of diabetes mellitus.
Cavallerano, J. D. (1990) · PubMed · Cited by 10 · see citing works
Flagged first, then by citations
Research works printed but not linked: 12
- Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18:258-68.
- Henriques J, et al. Doença ocular diabética, Acta Med Port 2015 Jan-Feb;28(1):107-113 Observatório Nacional da Diabetes 11/2013. Lisboa: OND; 2013.
- Nabais C, Pereira J, Pereira P, Capote R, Morbeck S, Raposo J. Retinopatia diabética e condições associadas, que relação? Um estudo em doentes com diabetes mellitus tipo 2. Acta Med Port. 2011;24:71-8.
- Marinho Falcão I, Pinto C, Santos J, Fernandes MF, Ramalho L, Paixão E, et al. Estudo da prevalência da diabetes e das suas complicações numa coorte de diabéticos portugueses: um estudo na Rede Médicos - Sentinela. Rev Port Clin Geral. 2008;24:679-92.
- Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227-39.
- Goldin A, Beckam JA, Schmidt AM, Creager MA. Advanced glycation en products: sparking the development of diabetic vascular injury. Circulation. 2006;114:597-605.
- Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999;84:489-97.
- Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:766-85.
- Mitchell P, Bandello F, Schmidt-Erfuth U, Lang GE, Masin P, Schlingeman RO, et al. The RESTORE study: ranibzumab mono therapy or combined with laser versus laser mono therapy for diabetic macular edma. Ophtalmology. 2011;118:615-25.
- Henriques J, Nascimento J, Rosa PC, Vaz FT, Amaro M. Laser fototérmico e sua interacção com a retina humana. Oftalmologia. 2012;36:353-64.
- Shen X, Zhong Y, Xie B, Cheng Y, Jiao Q. Pigment epithelium derived factor as an anti-inflammatory factor against decrease of glutamine synthetase expression in retinal Müller cells under high glucose conditions. Graef Arch Clin Exp Ophthalmol. 2010;248:1127-36.
- Negi A, Vernon SA. An overview of the eye in diabetes. J R Soc Med. 2003;96:266-72.
Cited by
Sorted by citations
Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy
Capitão, M., & Soares, R. A. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25575 · Cited by 310 · see citing works
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231 · see citing works
Ocular Complications of Diabetes and Therapeutic Approaches
Vieira‐Potter, V. J., Karamichos, D., & Lee, D. J. (2016) · BioMed Research International · doi:10.1155/2016/3801570 · Cited by 167 · see citing works
Priyadarsini, S., McKay, T. B., Sarker‐Nag, A., Allegood, J. C., Chalfant, C. E., Ma, J., & Karamichos, D. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.10.010 · Cited by 58 · see citing works
“DISCUSSION Diabetes is a systemic metabolic disease that affects nearly every tissue in the body, including the cornea (Henriques et al., 2015; Liu et al., 2015).”
BackgroundPan, L.-Y., Kuo, Y.-K., Chen, T., & Sun, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.980714 · Cited by 46 · see citing works
Potential Biomarkers in Diabetic Retinopathy
Adki, K. M., & Kulkarni, Y. A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200217092022 · Cited by 39 · see citing works
Zhang, L. J., van Dijk, E. H. C., Borrelli, E., Fragiotta, S., & Breazzano, M. P. (2023) · Diagnostics · doi:10.3390/diagnostics13020232 · Cited by 37 · see citing works
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases
Xia, F., Wang, Y., Xue, M., Zhu, L., Jia, D., Shi, Y., Gao, Y. M., Li, L., Li, Y., Chen, S., et al. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.07.003 · Cited by 25 · see citing works
“It was reported that diabetic retinopathy (DR) was the most notable microvascular complication and the main cause of low vision and visual loss among people aged 15 to 64.(57) A recent study found that KCNQ1OT1 competitively bound to miR-1470 to regulate epidermal growth factor receptor (EGFR) in DR, which affected th…”
BackgroundZhao, H., & He, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.723625 · Cited by 20 · see citing works
Zeng, X., Peng, Y., Wang, Y., & Kang, K.-M. (2022) · Bioengineered · doi:10.1080/21655979.2022.2031413 · Cited by 17 · see citing works
Capacity building for diabetic retinopathy screening by optometrists in India
Rani, P. K., Peguda, H. K., Chandrashekher, M., Swarna, S., Jonnadula, G. B., James, J., Shinde, L., & Bharadwaj, S. R. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1944_20 · Cited by 14 · see citing works
Spleen Tyrosine Kinase Mediates Microglial Activation in Mice With Diabetic Retinopathy
Liu, X., Xu, B. Y., & Gao, S.-H. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.4.20 · Cited by 14 · see citing works
Yang, Y., & Wang, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-35908-9 · Cited by 14 · see citing works
Vaz-Pereira, S., Morais-Sarmento, T., & Engelbert, M. (2021) · Diagnostics · doi:10.3390/diagnostics11101869 · Cited by 13 · see citing works
Self-citationWan, Z., Wan, J., Cheng, W., Yu, J., Yan, Y., Tan, H., & Wu, J. (2023) · Applied Sciences · doi:10.3390/app13116569 · Cited by 11 · see citing works
MiR-423-5p promotes Müller cell activation via targeting NGF signaling in diabetic retinopathy
Liu, Y., Xu, Z., Zheng, H., Yang, J., Wu, M., Yang, Q., Wang, Y., Zong, T., Yang, X., Xie, T., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122217 · Cited by 11 · see citing works
Prevalence and Severity of Dry Eye Disease Symptoms Among Diabetics: A Nationwide Survey
Almohammed, B. A., Alnafeesah, A. A., Aldharman, S. S., Alenzi, M. H., Mahjari, A. A., Albalawi, F., Amer, K. A. N., Alkhathami, G. H., & Taisan, A. A. A. (2022) · Cureus · doi:10.7759/cureus.30981 · Cited by 10 · see citing works
Metabolomics and biomarkers in ocular matrix: beyond ocular diseases
Luo, Y. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.06.21 · Cited by 10 · see citing works
Fundoscopy findings of diabetic and/or hipertensive patients
Menezes, L. D. M., & Morais, N. N. D. A. (2020) · Revista Brasileira de Oftalmologia · doi:10.5935/0034-7280.20200005 · Cited by 7 · see citing works
CURRENT MEASURES AGAINST OPHTHALMIC COMPLICATIONS OF DIABETES MELLITUS-A SHORT REVIEW
MANORMA, Mazumder, R., Rani, A., BUDHORI, R., & Kaushik, A. (2021) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2021v13i6.42876 · Cited by 6 · see citing works
Wang, J., Zhao, Y., Yang, X., Li, C., Liu, K., Ma, C., Jiang, Y., & Li, J. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.170369 · Cited by 5 · see citing works
Zhang, M., Dong, Z., Dong, W., Zhou, D., & Ren, X. S. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11610 · Cited by 5 · see citing works
Sanches, A. L., Leite, S., Nunes, A., Caixinha, M., Monteiro, P., & Nunes, A. (2023) · Acta Médica Portuguesa · doi:10.20344/amp.18557 · Cited by 3 · see citing works
PERFIL CLÍNICO-LABORATORIAL E COMPROMETIMENTO VASCULAR EM PACIENTES COM DIABETES MELLITUS TIPO 2
Chaves, R. L., & Anghebem-Oliveira, M. I. (2016) · Arquivos de Ciências da Saúde da UNIPAR · doi:10.25110/arqsaude.v20i1.2016.5467 · Cited by 2 · see citing works
Neuro-ophthalmological manifestations of diabetes mellitus during COVID-19-related lockdown in India
Kowsalya, A., Chaudhary, S., Sen, S., Shanmugam, M., Narayanamoorthy, J. K., Jain, S., & Sundar, B. (2022) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_558_22 · Cited by 2 · see citing works
“[6] In the eye, it can cause retinopathy, cataract, glaucoma, and neuro‐ophthalmic manifestations.[7] The most common neuro‐ophthalmological manifestations of diabetes are non‐arteritic anterior ischemic optic neuropathy (NAION) and ocular motor disorders resulting from third, sixth or fourth cranial nerve palsies.”
BackgroundShedding light on pharmacoepidemiology of eye diseases: a cohort study in Western Iran
Mousavi, Z., Bagheri, M., Najafi, F., Yavari, M., Bahiraee, O., & Moradinazar, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-09889-w · Cited by 1 · see citing works
Che, M., Xia, Z., Jiang, D., Wang, Y., Wang, H., Chen, Y., Wang, Z., Chen, Y., Zhang, X., Zhang, Z., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15243 · Cited by 1 · see citing works
Loganathan, R., & Latha, S. (2025) · Technology and Health Care · doi:10.1177/09287329241301649 · Cited by 1 · see citing works
Ophthalmic Disease in Diabetes
Henriques, J., Vaz-Pereira, S., Nascimento, J., Dutra-Medeiros, M., Henriques, S., & Rosa, P. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_49
Self-citationHu, L., Zhang, R., Wu, J., Feng, C., & Jiang, J. (2022) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2022.3104
Ophthalmic Disease in Diabetes
Henriques, J., Vaz-Pereira, S., Nascimento, J., Dutra-Medeiros, M., Henriques, S., & Rosa, P. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_53
Self-citationSomeshwaran, G., Srinivasan, S., Pavithra, A., Devi priya, R., Indhuvarshini, G., & Komathy, G. (2026) · ITM Web of Conferences · doi:10.1051/itmconf/20268203006
“Outside ophthalmology, OCT has been found to uncover biological markers for conditions such as diabetic retinopathy [5], eye pressure disorder [6], neurological disorder [7], and others, broadening its diagnostic uses [11].”
Zheng, K., Yang, D., Sun, X., Qu, S., Chu, L., Huang, S., Huang, Y.-J., Yang, Y., Qi, W., Zhang, F., et al. (2026) · Nutrients · doi:10.3390/nu18142326
“Long-term high blood sugar has been found to damage the structure of retinal blood vessels, causing leakage, ischemia, and abnormal neovascularization [21,22].”
- Authors
- Henriques, J., Vaz-Pereira, S., Nascimento, J., & Rosa, P. C.
- Affiliations
- Instituto de Oftalmologia Dr Gama Pinto (PT)
- University of Lisbon (PT)
- Hospital Beatriz Ângelo (PT)
- Venue
- Acta Médica Portuguesa
- Publisher
- Ordem dos Medicos
- Published
- 2015-02-27
- Volume
- 28
- Issue
- 1
- Pages
- 107-113
- ISSN
- 0870-399X (ISSN-L)
- 1646-0758
- OpenAlex
- W1758311627
- Cited by
- 33
- References
- 40
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 7 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 1 · 2016: 4
- FWCI
- 1.28
- Type
- journal article
- Language
- pt
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Médica Portuguesa (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal and Optic Conditions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic retinopathy, diabetes mellitus, microvascular complications, diabetic cataract, diabetic glaucoma, ischemic optic neuropathy, cranial nerve palsy, recurrent corneal erosion syndrome, blindness, early diagnosis
- MeSH terms
- Diabetic Retinopathy, Eye Diseases, Humans, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
